After Hours
$
3.97
Change
+0.09 +2.32%
Volume
Volume 5,417
May 16, 2022, 4:31 p.m.
Quotes are delayed by 20 min
Today's close
$ 3.99
$ 3.88
Change
-0.11 -2.76%
Day low
Day high
$3.86
$4.08

52 week low
52 week high
$3.52
$19.37

Market cap
$743.23M
Average volume
4.66M
P/E ratio
N/A
Rev. per Employee
$139,300
EPS
-2.67
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on NKTR
-
Nektar Therapeutics Will Cut 70% of Its Staff After Trial Failure
- Barron's Online
-
Nektar to reduce workforce by 70%
- Jaimy Lee
-
Nektar Therapeutics Stock Tanks Nearly 40%
- Barron's Online
-
Nektar Therapeutics stock price target cut to $6 from $8 at Mizuho
- Tomi Kilgore
-
10 Beaten-Down Stocks Where Short Sellers Are Now Retreating
- Barron's Online
-
Nektar Therapeutics downgraded to neutral from buy at Mizuho
- Tomi Kilgore
-
Nektar Therapeutics stock price target cut to $8 from $35 at Mizuho
- Tomi Kilgore
-
Nektar Shares Halve on Cancer Trial Failure
- Barron's Online
-
Nektar Therapeutics upgraded to outperform from perform at Raymond James
- Tomi Kilgore
-
SolarEdge, FactSet and Signature Bank to join S&P 500 index
- Claudia Assis
-
Nektar Therapeutics downgraded to hold from buy at Benchmark
- Tomi Kilgore
-
Nektar Therapeutics initiated at hold with $18 price target at Stifel
- Tonya Garcia
-
Nektar Therapeutics started at buy with $26 stock price target at Benchmark
- Tomi Kilgore
-
Beyond Meat Stock Is Dropping, Aphria Rises as the Dow Edges Down
- Barron's Online
- Loading more headlines...
Analyst Ratings
-
Wall Street Is Bullish on Nektar Stock despite Stock Price Slump
- MarketRealist.com
-
Benzinga's Top Analyst Calls From April 6, 2018
- Benzinga.com
-
Benzinga's Top Upgrades, Downgrades For April 2, 2018
- Benzinga.com
Other News on NKTR
-
Cue Biopharma: A First Assessment
- Seeking Alpha
-
Bristol-Myers Has the Stalest Product Line, Says Evaluate
- GuruFocus.com
-
- Edgar Online - (EDG = 10Q, 10K)
-
Nektar cancer drug improves anti-tumor effect of CAR T drugs
- Seeking Alpha
-
Regenxbio: Is The Ultimate Catalyst Coming?
- Seeking Alpha
-
- Seeking Alpha
-
VIRX, ARQQ and GWGH among mid-day movers
- Seeking Alpha
-
Why Nektar Therapeutics Stock Is Crashing Today
- Motley Fool
- Loading more headlines...
Press Releases on NKTR
-
What to Know About Buying Penny Stocks on May 11th
- Penny Stocks
-
Nektar Therapeutics Reports First Quarter 2022 Financial Results
- PR Newswire - PRF
-
Monday Sector Laggards: Drugs, Biotechnology Stocks
- MarketNewsVideo.com
-
Monday Sector Laggards: Drugs, Biotechnology Stocks
- MarketNewsVideo.com
-
Nektar Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com